- Active infection, cellulitis, or dermatitis at the site of administration.

- Known allergy or hypersensitivity to the drug.

- Acute myocardial infarction- the release of muscle enzymes complicate the management strategy.

- Thrombocytopenia.

- Coagulation defects.

- Hypovolemic shock - the drug's absorption may be hampered due to compromised vascularity of the muscle.

- Myopathies.

- Associated muscular atrophy - leads to delayed drug absorption and increases the risk of neurovascular complications.